Eli Lilly announces investment of up to $250M in Purdue University

Eli Lilly (LLY) and Company and Purdue University announced a significant expansion of their long-standing alliance, with Lilly’s planned investment of up to $250M in the collaboration over the next eight years. This partnership, which has the potential to be the largest ever industry-academic agreement of its kind in the United States, will seek to accelerate innovation at every stage of the pharmaceutical pipeline. The Lilly-Purdue 360 Initiative aims to achieve several key goals, including discovering and accelerating the delivery of medicines to patients; bridging the gap between laboratory discoveries and clinical applications; creating more resilient, efficient and sustainable supply chains; and deploying innovative, scalable approaches to workforce development. The expanded collaboration is also expected to generate significant economic benefits for Indiana by creating a highly skilled workforce and fostering local innovation. The earlier agreement, which had been set to expire in 2027, will now extend with four new projects added through 2032.